logo
Deal or No Deal? Inside India's high-stakes trade gamble with the US

Deal or No Deal? Inside India's high-stakes trade gamble with the US

India Today7 hours ago

When Indian and American negotiators sat across the table in New Delhi from June 5 to 7, the atmosphere was businesslike but charged. The stakes were higher than ever. On one side stood President Donald Trump, newly re-elected, charging into his second term with economic nationalism as his war cry. On the other, Prime Minister Narendra Modi, having just secured a third term, was recalibrating India's global economic engagement with a sharpened sense of sovereignty. The long-pending limited trade deal between India and the United States—which had simmered unresolved since Trump's first tenure—was back on the table, but under new political compulsions and strategic calculations. India and the US aim to double bilateral trade to $500 billion by 2030.For Washington, this deal is no longer about symbolism or goodwill. The Trump administration, determined to rewrite global trade on its own terms, sees the Indian market as both an untapped export opportunity and a strategic wedge against Chinese dominance. But unlike in earlier phases, there is little appetite for compromise in Trump's America. Every trade pact must now deliver visible benefits for American jobs and exporters. Anything less risks being branded a loss—especially in the high-decibel domestic climate leading into the 2026 US midterms. The President has repeatedly signalled that past arrangements were too generous to countries like India, which he claims have long taken advantage of American openness. With this in mind, US trade officials arrived in Delhi with a short but pointed agenda—remove tariff barriers, open up sensitive sectors, and secure digital and regulatory commitments that align with corporate America's interests.advertisementIndia, however, is not the same player it was during earlier trade rounds. Over the past few years, New Delhi has rebuilt its strategic and economic confidence. Its global standing has improved, its exports diversified, and its domestic market deepened. But more importantly, there has been a clear shift in how trade is approached in policy circles—moving from passive liberalisation to active negotiation. India is no longer eager to sign deals merely for optics or as diplomatic sweeteners. The experience of asymmetric free trade agreements in the past, and the lessons from rejecting the Regional Comprehensive Economic Cooperation (RCEP), have deeply informed the present stance.As of 2025, India is in talks with major partners, including the EU and ASEAN, while also exploring new agreements with Africa, Latin America and the Arab Gulf. The emphasis now is on aligning trade with national development goals, safeguarding regulatory space, and building domestic capabilities in key sectors such as digital infrastructure, clean energy and pharmaceuticals.advertisement
What makes this negotiation different is not just the hardened positions on both sides but the strong presence of ideological and institutional voices in India pushing back against what they perceive as a lopsided deal. Over the past months, affiliates of the Rashtriya Swayamsevak Sangh, including the Swadeshi Jagran Manch, have flagged several red lines for Indian negotiators. These are not merely academic critiques but deeply rooted ideological objections that enjoy resonance in key segments of the ruling political ecosystem. Encouragingly for them, India's official position appears to be largely aligned with many of their concerns.Meanwhile, another letter from 20 former officials—including former cabinet secretary K.M. Chandrasekhar, G.K. Pillai, Ujal Singh Bhatia, Amarendra Khatua and Sanjaya Baru—along with some economists, cautioned New Delhi to 'walk away' from a lopsided deal. They note that without a trade promotion authority in the US, any concessions would be limited to Trump-era executive tariffs—not durable legal changes—and that compromising India's core interests today could result in long-term sovereignty loss. In short, they argue that temporarily closed doors on US markets may be better than structurally weakened regulatory autonomy.Various Sangh affiliates have their own set of red flags, but at the top of the list is digital sovereignty. The US wants binding commitments on cross-border data flows, curbs on data localisation and relaxed regulation for American digital firms operating in India. Indian negotiators have reportedly resisted these asks. There is a growing recognition in New Delhi that accepting such provisions would jeopardise the integrity of India's digital public infrastructure—UPI, Aadhaar, DigiLocker, ONDC—all of which are premised on public control over data and technology ecosystems. The fear is that Big Tech companies could use trade deals as Trojan horses to dismantle domestic regulatory autonomy, reduce accountability and monopolise critical sectors. For the Swadeshi camp, this is not just a technical debate—it is about ensuring that India's digital future is not outsourced to Silicon Valley giants under the garb of free trade.advertisementAnother major point of friction lies in the area of intellectual property rights, especially in pharmaceuticals. The US pharma lobby has long pressured India to adopt TRIPS-plus provisions—ranging from extended patent terms and patent linkage to the dilution of compulsory licensing. But for India, these are red lines. The country's success as the world's leading supplier of affordable generics, including vaccines, depends on a flexible intellectual property regime that prioritises public health over monopolies. The battle over Section 3(d) of the Indian Patents Act—designed to prevent evergreening of patents—is emblematic of the larger ideological divide. Domestic lobbies and health policy experts have argued that compromising on this front would not only increase the cost of medicines for Indian citizens but also damage India's global standing as the pharmacy of the Global South.advertisementThe agriculture front has also emerged as a flashpoint. The US has pushed for greater market access for genetically modified crops, chlorine-washed poultry and hormone-treated dairy products. For Indian negotiators, this is politically and economically sensitive territory. Indian farmers operate in vastly different conditions—small holdings, traditional practices and a deep reliance on biodiversity. Introducing GMOs or industrial food products without adequate safeguards could destabilise local supply chains, damage soil health and displace small farmers. The RSS and its affiliates have repeatedly warned against diluting the precautionary principle in food safety, pointing out that long-term food sovereignty cannot be compromised for short-term tariff relief.The Trump administration's insistence on restoring tariff benefits under the Generalized System of Preferences (GSP) only if India allows market access for such products has complicated the talks further. Indian negotiators have remained firm, citing consumer safety, regulatory autonomy and domestic sensitivities. With Washington pushing hard for its agro-export lobbies, especially on GM corn, soy and dairy, Indian officials worry such concessions could open the floodgates for unsustainable imports and threaten food security. This deadlock underscores the deeper tensions between trade liberalisation and India's developmental and agricultural imperatives.advertisementAnother contentious American demand is the inclusion of an Investor-State Dispute Settlement (ISDS) mechanism, which would allow US firms to sue the Indian government in international arbitration forums if they believe domestic laws have hurt their profits. The Indian side has reportedly flatly rejected this, consistent with its stance in other FTAs over the past decade. ISDS provisions are viewed as a serious threat to India's sovereign policy space and judicial process. Past experiences with multinational disputes have made it clear that such mechanisms often bypass domestic courts and leave the country exposed to disproportionate liabilities. The Swadeshi camp argues that any dispute resolution framework must be reciprocal, limited in scope and rooted in Indian legal institutions.Beyond the big-ticket issues, there are more subtle but equally significant concerns. American negotiators have insisted on liberalisation in strategic sectors such as e-commerce, defence production, clean energy and agri-logistics. While India has opened selectively in these areas, full-scale liberalisation without safeguards could be disastrous for local firms, cooperatives and startups. The domestic lobby advocates a calibrated approach—one that combines FDI caps, localisation mandates and domestic value-addition norms to protect India's long-term industrial interests.advertisementThere is also unease about the growing trend of inserting side chapters in trade agreements—covering labour standards, gender rights, environmental norms and civil society engagement. While these may appear progressive, Swadeshi voices caution that they often serve as pressure points for future litigation or reputational coercion. The preference is for India to evolve its own ESG standards, rooted in its civilisational values, livelihood priorities and federal structure—not adopt imported frameworks that may not suit Indian realities.Finally, there is growing awareness that trade liberalisation often overlooks cultural and traditional knowledge systems—Ayurveda, handicrafts, tribal knowledge and local foods—that don't fit into Western IPR definitions. These represent real economic capital for India, particularly for rural and indigenous communities. RSS affiliates have pushed for stronger protection of geographical indications, cultural commons and rural creative industries within trade negotiations.This rising chorus of Swadeshi caution has not gone unnoticed. Many of India's recent trade decisions—including the cautious pace of the FTA with the UK and the shelving of RCEP—reflect a deeper institutional consensus that unbalanced deals are no longer acceptable. Recent warnings by retired trade negotiators and policy veterans have only added weight to this stance. They argue that New Delhi must be ready to walk away if the deal appears skewed, urging the government not to trade long-term autonomy for short-term optics. The sentiment is increasingly shared by officials across ministries: India can afford patience, but not policy capture.Meanwhile, the American side is feeling the pressure to deliver. Trump's trade doctrine, powered by his electoral calculus, leaves little room for nuanced diplomacy. Deals must be announced with a bang. Benefits must be quantifiable. And foreign governments must be shown to have conceded. In such an environment, India's insistence on a balanced, development-friendly deal risks being read in Washington as resistance. Yet New Delhi appears ready to absorb that cost, preferring friction over folly.The latest round in New Delhi ended without a final breakthrough, but with enough movement to suggest the door remains open. Both sides are expected to hold another round later this summer. But the message from India is increasingly clear: the era of trade policy as a diplomatic concession is over. What replaces it is a new framework—pragmatic, sovereign and deeply aware of the ideological choices embedded in every clause. For a country aspiring to be Vishwaguru, mastering the art of tradecraft is no longer optional. It is a strategic necessity.Subscribe to India Today Magazine

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Donald Trump Says Pharma Tariffs 'Coming Soon'; Indian Drug Stocks Fall Up To 4%
Donald Trump Says Pharma Tariffs 'Coming Soon'; Indian Drug Stocks Fall Up To 4%

News18

time24 minutes ago

  • News18

Donald Trump Says Pharma Tariffs 'Coming Soon'; Indian Drug Stocks Fall Up To 4%

Last Updated: US Pharma Tariffs: Granules India becomes the top loser falling up to 4%, while Aurobindo, Natco and Lupic was down 3% each. US President Donald Trump on June 17 said tariffs on the pharmaceutical sector are 'coming soon". Following comments, which Trump made while speaking to reporters on board the Air Force One, India's pharma stocks declined up to 4%. The Nifty Pharma index declined as much as 2.5% following the Trump comments. Granules India became the top loser falling up to 4%, while Aurobindo, Natco and Lupic was down 3% each. This isn't the first warning — back in April, after imposing reciprocal tariffs on 60 countries (excluding pharma at the time), Trump had hinted that pharma tariffs would come in at 'never seen before" levels and were under active review. 'Pharma tariffs are going to come in at levels you haven't really seen before. We are looking at pharmaceuticals as a separate category. We will be announcing that sometime in the near future, and not too distant future. It's under review right now," Trump had said back in April. The US Commerce Department is currently investigating pharma imports under Section 232, which evaluates the impact of imports on national security. If such tariffs are imposed and companies are unable to pass on the cost, analysts at Citi estimate Indian firms with high exposure to the US generics market could see a 9%-12% one-time hit to their Ebitda.

Donald Trump's Iran policy divides MAGA: Vance defends, Marjorie Taylor Greene & Tucker Carlson oppose
Donald Trump's Iran policy divides MAGA: Vance defends, Marjorie Taylor Greene & Tucker Carlson oppose

Mint

time26 minutes ago

  • Mint

Donald Trump's Iran policy divides MAGA: Vance defends, Marjorie Taylor Greene & Tucker Carlson oppose

JD Vance took to X (formerly Twitter) on Tuesday (June 17) to defend President Donald Trump's handling of the Iran-Israel conflict, pushing back against growing dissent from within the MAGA movement. 'The president has shown remarkable restraint,' Vance wrote, insisting Trump remains committed to preventing Iran from acquiring nuclear weapons. 'He is only interested in using the American military to accomplish the American people's goals,' Vance said. In his detailed post, Vance emphasised the distinction between civilian nuclear power and uranium enrichment, claiming Iran crossed the line by enriching uranium well beyond civilian use thresholds. 'Iran could have civilian nuclear power without enrichment, but Iran rejected that,' Vance explained. 'It's one thing to want civilian nuclear energy. It's another thing to demand sophisticated enrichment capacity.' He cited findings from the International Atomic Energy Agency (IAEA), accusing Iran of violating its non-proliferation obligations. While acknowledging public skepticism about foreign interventions, Vance urged Americans to trust Trump's judgment on the issue. 'He may decide he needs to take further action to end Iranian enrichment,' Vance wrote. 'That decision ultimately belongs to the president.' 'I believe the president has earned some trust on this issue.' Vance's defense of Trump arrives as high-profile MAGA conservatives voice growing concern over possible US military involvement in the Iran-Israel conflict. Tucker Carlson and Rep. Marjorie Taylor Greene have emerged as leading voices in the internal rebellion. Greene warned on June 16 that U.S. foreign interventions 'put America last' and 'will ultimately lead to our destruction.' 'Anyone slobbering for the U.S. to become fully involved in the Israel/Iran war is not America First/MAGA,' she posted on X. Greene added that Americans are 'sick and tired of foreign wars' and want troops focused on protecting US borders. Carlson went further, accusing Trump of being 'complicit in the act of war.' The former Fox News host's comments sparked a rare criticism from Trump, who dismissed him publicly. 'I don't know what Tucker Carlson is saying. Let him go get a television network and say it so that people listen,' Trump said. On Truth Social, he added: 'Kooky.'

Next No Kings protests date released as millions turn out on Trump birthday - Date, time, venue and all details
Next No Kings protests date released as millions turn out on Trump birthday - Date, time, venue and all details

Economic Times

time28 minutes ago

  • Economic Times

Next No Kings protests date released as millions turn out on Trump birthday - Date, time, venue and all details

When is Next "No Kings" protest? Live Events What themes will the next 'No Kings' rally focus on? Were there any incidents during the June 14 protests? FAQs (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Following the massive turnout on Donald Trump's birthday, " No Kings " organizers have set the next protest date. With millions already marching, momentum is gaining again, this time with a renewed emphasis on justice and voting against growing authoritarianism, known as the "No Kings" movement, started all over the United States on June 14. This event was deemed a nationwide day of organizers of last weekend's "No Kings" protests are already planning another rally and are hailing the event as one of the biggest mass gatherings in American mobilizing millions around the world on June 14, the Transformative Justice Coalition said Monday that in remembrance of Civil Rights activist and lawmaker John Lewis, who passed away on that day in 2020, the next protests will take place on July upcoming demonstrations will focus on racial justice, voting rights, and democracy. The previous round of protests included more than 2,100 global Levin of Indivisible reports that more than 2,100 No Kings events were held in 20 countries on Saturday. Approximately 5 million people worldwide took part, Levin added."We're going to center three things," Barbara Arnwine of the Transformative Justice Coalition stated in reference to the planned protests on July would prioritize voting rights for all, as voter suppression has no right to exist in this will prioritize racial justice because this country will never be right until it is racially just. 'Lastly, they will discuss our ongoing and unified struggle for a robust, inclusive, and just democracy, which is our mission and our duty in these times,' as per a report by preparations are underway for the upcoming No Kings demonstrations on Saturday were mostly nonviolent, but there were a few incidents. Arthur Folasa Ah Loo, 39, was shot and killed during the No Kings demonstration in Salt Lake Woodard Henderson, the call's host on Monday, provided a GoFundMe link in order to help the family of Folasa Ah next nationwide protest is on July 17. Locations are being confirmed, but events will be held throughout the United rallies will focus on racial justice, voting rights, and democracy-building, echoing John Lewis' legacy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store